- Home
- NAMS vs INTA Comparison
NAMS vs INTA Comparison
Compare NAMS & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | INTA |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | Netherlands | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAMS | INTA |
|---|---|---|
| Price | $22.78 | $36.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $46.75 | $41.43 |
| AVG Volume (30 Days) | ★ 1.7M | 532.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $22,503,000.00 | ★ $577,805,000.00 |
| Revenue This Year | $17.96 | $15.91 |
| Revenue Next Year | $540.65 | $13.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.62 |
| 52 Week Low | $21.02 | $19.01 |
| 52 Week High | $42.21 | $47.93 |
Technical Indicators
Market Signals| Indicator | NAMS | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 42.90 |
| Support Level | $21.02 | $20.15 |
| Resistance Level | $37.26 | $44.33 |
| Average True Range (ATR) | 1.53 | 1.53 |
| MACD | 0.19 | -0.51 |
| Stochastic Oscillator | 32.69 | 17.48 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.